AAVogen, Inc.
PrivateLast Round
Grant
Sep 5, 2025
Total Funding Raised
$4.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AAVogen, Inc. is a biotechnology company that develops gene therapeutics for muscle wasting diseases such as inclusion body myositis, Duchenne muscular dystrophy, and heart failure.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AAVogen, Inc. Comparables
Compare AAVogen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MyoGene Bio | 84% | |
| Myosana Therapeutics | 83% | |
| Orphina Biotechnology | 82% | |
AAVogen, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 5, 2025 | ||||
| Grant | Jun 10, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
| Grant | Sep 1, 2019 | ||||
| Grant | Sep 1, 2017 | ||||
Grant | Dec 3, 2016 |
Key People
Founding team and executive leadership
AAVogen, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| Washington State University | Grant |
| National Institute on Aging | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Washington Research Foundation Capital | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 105% MoM.
- May 15, 2026
Monthly visitors grew 264% MoM, reaching 1.1K.
AAVogen, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AAVogen, Inc.'s valuation, stock price, and market status.